Cases / Investigations

MiMedx Group, Inc.


Wolf Popper LLP Announces Investigation on Behalf of Investors in MiMedx Group, Inc.

NEW YORK, February 20, 2018

Wolf Popper LLP is investigating potential securities fraud claims on behalf of investors in MiMedx Group, Inc. (NASDAQ: MDXG).  MiMedx investors should contact Fei-Lu Qian at 877.370.7703 or at fqian@wolfpopper.com.

On February 20, 2018, before the market opened, MiMedx issued a press release disclosing the delay in the release of its fourth quarter 2017 financial results as its Audit Committee is conducting “an internal investigation into current and prior-period matters relating to allegations regarding certain sales and distribution practices at the Company.”  MiMedx is “also reviewing, among other items, the accounting treatment of certain distributor contracts.”

As a result of the disclosure, MiMedx stock price declined more than $4.50 per share on intraday trading on February 20, 2018.

Wolf Popper has successfully recovered billions of dollars for defrauded investors.  The firm’s reputation and expertise have been repeatedly recognized by the courts, which have appointed the firm to major positions in securities litigation.  See www.wolfpopper.com.

Attorney Advertising: Prior Results Do Not Guarantee A Similar Outcome.

Wolf Popper LLP
Fei-Lu Qian
845 Third Avenue
New York, NY 10022
Tel.: 877.370.7703
Fax: 877.370.7704
Email: fqian@wolfpopper.com


Related Practice Area